直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Workshop

Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 2, 2024

Cambridge, MA

Finnegan

Register 

We look forward to hosting our annual in-person seminar covering a wide-range of patent, trademark, copyright, and data privacy developments for the Boston life sciences community. Please join us for a lively discussion of key legal precedents and best practices for 2024. Topics will include:

    • Strategies for streamlining IP due diligence and effectively executing complex transactions
    • Trademark, copyright, and advertising protections and enforcement modalities in the U.S. and Europe
    • Data privacy and uncertainties around artificial intelligence in the development and commercialization processes
    • Leveraging the Unified Patent Court (UPC) for life science companies, including a briefing of the Amgen/Sanofi dispute at the UPC
    • Case law updates in the U.S.: Xencor, Cellect, written description and enablement considerations, and additional trends to watch this year

Presenters:
Lin Ao
Marta Garcia Daneshvar
Lynn Parker Dupree
Emily Gabranski
Scott Forman
Jeffrey Jacobstein
Laura Johnson
Nishla Keiser
Sara Leiman
Jenevieve Maerker
Victoria Randall

Tags

Unified Patent Court (UPC)

Related Practices

Diligence, Licensing, and Opinions

Privacy

Licensing, Pooling, and Other Transactions

Due Diligence

Global IP Enforcement, Litigation, and Trials

Trademark Litigation and Trials

Patent Litigation and Trials

Prosecution and Portfolio Management

Patent Drafting and Prosecution

IP Portfolio Management

Trademark and Brand Management

Trademark Counseling and Prosecution

Copyright

Advertising

Related Industries

AI, Electronics, and Information Technology

Artificial Intelligence (AI) and Machine Learning (ML)

Life Sciences

Pharmaceutical

Biotechnology

Related Offices

Boston, MA

London

Washington, DC

Related Professionals

Lynn Parker Dupree
Partner
Washington, DC
+1 202 408 4462
Email
Emily R. Gabranski
Partner
Washington, DC
+1 202 408 4331
Email
Jeffrey M. Jacobstein
Partner
Boston, MA
+1 617 646 1664
Email
Laura K. Johnson
Partner
Boston, MA
+1 617 646 1645
Email
Jenevieve J. Maerker
Of Counsel
Boston, MA
+1 617 646 1655
Email
Victoria A. Randall, Ph.D.
Partner
London
+44 (0)20 7864 2812
Email
Lin Ao, Ph.D.
Associate
Boston, MA
+1 617 646 1624
Email
Sara A. Leiman, Ph.D.
Associate
Boston, MA
+1 617 646 1651
Email

Related Insights

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Seminar

3rd AI, IP, & Legal Forum

June 6, 2026

Shangai

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

Conference

BIA Start-up Festival

May 21, 2026

London

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP